An increased fraction of circulating miR-363 and miR-16 is particle bound in patients with chronic lymphocytic leukaemia as compared to normal subjects.

• Published in: BMC Research Notes
• Main Authors: Alharthi, Afaf, Beck, Daniel, Howard, Dena R., Hillmen, Peter, Oates, Melanie, Pettitt, Andrew, Wagner, Simon D.
• Format: Article in Journal/Newspaper
• Language: English
• Published: BioMed Central 2018
• Subjects: Chronic lymphocytic leukaemia; Extracellular vesicle; miRNA; Arctic; Leicester
• Online Access: https://bmcresnotes.biomedcentral.com/articles/10.1186/s13104-018-3391-9; http://hdl.handle.net/2381/42178; https://doi.org/10.1186/s13104-018-3391-9

The data that support the findings from the ARCTIC clinical trial (Reference 19) are available from the Leeds Clinical Trials Unit but restrictions apply to the availability of these data, which were used following completion of a Data Sharing Agreement between the universities of Leeds and Leiceste...